Anti-PD-1, IMiD combo immunotherapy active in heavily pretreated myelomaDecember 12, 2015Multiple Myeloma
VIDEO: Top-line results from Tourmaline in multiple myeloma, plus ongoing trials and treatment selectionDecember 7, 2015Multiple Myeloma
ASH: Daratumumab and len/dex produce high response rates in refractory myelomaDecember 7, 2015Multiple Myeloma
VIDEO: Targeted agent, len/dex combo perform ‘impressively’ in advanced multiple myelomaDecember 7, 2015Multiple Myeloma
ASH: Carfilzomib doubles progression free survival in head-to-head trial with bortezomibDecember 5, 2015Multiple Myeloma
Multiple myeloma advances in diagnosis, staging, therapy extend survivalNovember 11, 2015Multiple Myeloma
NCCN unveils 'Evidence Blocks' to facilitate treatment discussionsOctober 23, 2015Multiple MyelomaPatient & Survivor CareCML
